Patent References 3382152 3799883 3821351 3900551 Molybdenum recovery Preparation of a primary target for the production of fission products in a nuclear reactor Process for recovering molybdenum-99 from a matrix containing neutron irradiated fissionable materials and fission products Process for recovering molybdenum-99 from a matrix containing neutron irradiated fissionable materials and fission products Method for enhanced control of radioiodine in the production of fission product molybdenum 99 Separation of uranium and molybdenum using a solvent Patent #: 4363788 InventorsAssigneeApplicationNo. 06/806815 filed on 12/10/1985US Classes:423/2, Radioactive metal (At. No. 84+ or radioactive isotope of another metal)252/645, For tracing, tagging, or testing423/9Organo-nitrogen solventExaminersPrimary: Miller, Edward A.Attorney, Agent or FirmInternational ClassesC01G 39/00 (20060101)C22B 3/00 (20060101) C22B 3/32 (20060101) G21G 1/08 (20060101) G21C 19/42 (20060101) G21C 19/46 (20060101) G21G 1/00 (20060101) Foreign Application Priority Data1984-12-28 FRAbstractThe invention relates to a process for the recovery of molybdenum-99 from an irradiated uranium alloy target.This process comprises the following stages:(a) dissolving the irradiated uranium alloy target in sulphuric acid,(b) separating the iodine and tellurium present in the thus obtained solution,(c) oxidizing the molybdenum-99 present in the Mo (VI) solution, and(d) extracting the thus oxidized molybdenum-99 with a hydroxamic acid of formula: ##STR1## in which R is a radical chosen from the group including straight or branched-chain alkyl radicals, the phenyl radical, phenyl radicals substituted by at least one alkyl radical, arylalkyl radicals and the cyclohexyl radical and R' is a hydrogen atom or an alkyl radical.The hydroxamic acid can be tri-n-butylacetohydroxamic acid and the molybdenum recovered can be used in a technetium generator for medical purposes.Other References
|
| ||||||||||||||